Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Preliminary Validation of an Optimal Cutpoint in Total Number of Patient-Reported Symptoms in Head and Neck Cancer for Effective Alignment of Clinical Resources with Patients' Symptom Burden.
Van Cleave JH, Concert C, Kamberi M, Zahriah E, Most A, Mojica J, Riccobene A, Russo N, Liang E, Hu KS, Jacobson AS, Li Z, Moses LE, Persky MJ, Persky MS, Tran T, Brody AA, Kim A, Egleston BL. Van Cleave JH, et al. Among authors: kamberi m. Cancer Care Res Online. 2024 Jan;4(1):e051. doi: 10.1097/cr9.0000000000000051. Epub 2023 Nov 22. Cancer Care Res Online. 2024. PMID: 38586274
The development, usability, and reliability of the Electronic Patient Visit Assessment (ePVA) for head and neck cancer.
Van Cleave JH, Fu MR, Bennett AV, Persky MS, Li Z, Jacobson A, Hu KS, Most A, Concert C, Kamberi M, Mojica J, Peyser A, Riccobene A, Tran A, Persky MJ, Savitski J, Liang E, Egleston BL. Van Cleave JH, et al. Among authors: kamberi m. Mhealth. 2019 Jul 29;5:21. doi: 10.21037/mhealth.2019.06.05. eCollection 2019. Mhealth. 2019. PMID: 31463307 Free PMC article.
The usefulness of the Electronic Patient Visit Assessment (ePVA)© as a clinical support tool for real-time interventions in head and neck cancer.
Van Cleave JH, Fu MR, Bennett AV, Concert C, Riccobene A, Tran A, Most A, Kamberi M, Mojica J, Savitski J, Kusche E, Persky MS, Li Z, Jacobson AS, Hu KS, Persky MJ, Liang E, Corby PM, Egleston BL. Van Cleave JH, et al. Among authors: kamberi m. Mhealth. 2021 Jan 20;7:7. doi: 10.21037/mhealth-19-250. eCollection 2021. Mhealth. 2021. PMID: 33634190 Free PMC article.
Chemical Characterization of Leachables in Catheter Device.
Wang H, Yu H, Tran TN, Fu K, Kiley K, Kullar S, Hu J, Kamberi M. Wang H, et al. Among authors: kamberi m. ACS Omega. 2022 Dec 15;7(51):48291-48300. doi: 10.1021/acsomega.2c06473. eCollection 2022 Dec 27. ACS Omega. 2022. PMID: 36591149 Free PMC article.
Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model.
Campos CM, Ishibashi Y, Eggermont J, Nakatani S, Cho YK, Dijkstra J, Reiber JH, Sheehy A, Lane J, Kamberi M, Rapoza R, Perkins L, Garcia-Garcia HM, Onuma Y, Serruys PW. Campos CM, et al. Among authors: kamberi m. Int J Cardiovasc Imaging. 2015 Mar;31(3):471-82. doi: 10.1007/s10554-015-0591-4. Epub 2015 Jan 28. Int J Cardiovasc Imaging. 2015. PMID: 25627777 Free PMC article.
Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model.
Otsuka F, Pacheco E, Perkins LE, Lane JP, Wang Q, Kamberi M, Frie M, Wang J, Sakakura K, Yahagi K, Ladich E, Rapoza RJ, Kolodgie FD, Virmani R. Otsuka F, et al. Among authors: kamberi m. Circ Cardiovasc Interv. 2014 Jun;7(3):330-42. doi: 10.1161/CIRCINTERVENTIONS.113.000990. Epub 2014 Jun 3. Circ Cardiovasc Interv. 2014. PMID: 24895447
27 results